Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun:22:101350.
doi: 10.1016/j.pmedr.2021.101350. Epub 2021 Mar 12.

Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants

Affiliations

Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants

Shufang Sun et al. Prev Med Rep. 2021 Jun.

Abstract

With the demand for rapid COVID-19 vaccine development and evaluation, this paper aimed to describe the prevalence and correlates of willingness to participate in COVID-19 vaccine trials among university students in China. A cross-sectional survey with 1912 Chinese university students was conducted during March and April 2020. Bivariate and multivariate analyses were performed to identify variables associated with willingness to participate. The majority of participants (64.01%) indicated willingness to participate in COVID-19 vaccine trials. Hesitancy over signing informed consent documents, concerns over time necessary for participating in a medical study, and perceived COVID-19 societal stigma were identified as deterrents, whereas lower socioeconomic status, female gender, perception of likely COVID-19 infection during the pandemic, and COVID-19 prosocial behaviors were facilitative factors. Further, public health mistrust and hesitancy over signing informed consent documents had a significant interactive effect on vaccine trial willingness. High standards of ethical and scientific practice are needed in COVID-19 vaccine research, including providing potential participants full and accurate information and ensuring participation free of coercion, socioeconomic inequality, and stigma. Attending to the needs of marginalized groups and addressing psychosocial factors including stigma and public health mistrust may also be important to COVID-19 vaccine development and future uptake.

Keywords: COVID-19; China; Vaccine hesitancy; Vaccine trials willingness; Young adult.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
The interactive effect of public health mistrust X hesitancy over signing informed consent documents on the probability of being willing to participate in COVID-19 vaccine trials Note. Public health mistrust was mean-centered (M = 0, SD = 1). Grey area represents 95% confidence intervals. Main effects and effects of co-variates were accounted in modeling the figure.

Update of

Similar articles

Cited by

References

    1. Ahmed, F., Ahmed, N., Pissarides, C., Stiglitz, J., 2020. Why inequality could spread COVID-19. Lancet Public Heal [Internet] 5(5):e240. Available from: http://dx.doi.org/10.1016/S2468-2667(20)30085-2 PMID: 32247329. - PMC - PubMed
    1. Caprara G.V., Steca P., Zelli A., Capanna C. A new scale for measuring adults’ prosocialness. Eur. J. Psychol. Assess. 2005;21(2):77–89.
    1. Eisenman D.P., Williams M.V., Glik D., Long A., Plough A.L., Ong M. The public health disaster trust scale: Validation of a brief measure. J Public Heal Manag Pract. 2012;18(4):1–8. - PubMed
    1. Fadda, M., Albanese, E., Suggs, L.S., 2020. When a COVID-19 vaccine is ready, will we all be ready for it? Int. J. Public Health [Internet]. Springer International Publishing; 2020;4(Latimer). Available from: 10.1007/s00038-020-01404-4. - PMC - PubMed
    1. Harro C.D., Judson F.N., Gorse G.J., Mayer K.H., Kostman J.R., Brown S.J., Koblin B., Marmor M., Bartholow B.N., Popovic V. Recruitment and baseline epidemiologic profile of participants in the first phase 3 HIV vaccine efficacy trial. J. Acquir. Immune Defic. Syndr. 2004;37(3):1385–1392. - PubMed